| OLP | Control | P value | ||
---|---|---|---|---|---|
n | Result | n | Result | ||
Total number | 80 | Â | 51 | Â | Â |
Gender, n (%) | Â | Â | Â | Â | 0.381 |
 Male | 36 | 45 | 19 | 37.25 |  |
 Female | 44 | 55 | 32 | 62.75 |  |
Age, median (IQR) years | 80 | 43 (35.25 – 55) | 51 | 42 (33 – 51) | 0.18 |
Clinical type, n (%) | Â | Â | Â | Â | Â |
 Red-form | 41 | 51.25 |  |  |  |
 White-form | 31 | 38.75 |  |  |  |
 Not recorded | 8 | 10 |  |  |  |
Duration, median (IQR) months | 66 | 4.5 (2 – 6.25) |  |  |  |
CRP, n (%) | Â | Â | Â | Â | Â |
 ≥ 3.48 mg/L | 6 | 7.5 |  |  |  |
 < 3.48 mg/L | 74 | 92.5 |  |  |  |
BMI, mean (± SD) kg/m2 | 64 | 23.45 ± 3.29 |  |  |  |